Nettoinventarwert (NAV)
| 104.78 USD | USD | % |
|---|
| Vortag | USD | Datum | 31.10.2026 |
H1 Systematic US Allocation (Series 579) Notes due 2046 USD Acc Kurs - 1 Jahr
1W
3M
1J
3J
5J
MAX
Anzeige
| Name | ISIN | Performance | |
|---|---|---|---|
| 21Shares Raydium ETP | CH1480821391 | 186.00% | |
| 21Shares Stacks ETP | CH1258969042 | 147.57% | |
| 21Shares Arbitrum ETP | CH1304867463 | 132.92% | |
| 21Shares NEAR Protocol Staking ETP | CH1162108893 | 125.72% | |
| 21Shares Injective Staking ETP | CH1360612134 | 80.85% |
| Name | ISIN | Performance | |
|---|---|---|---|
| 21Shares NEAR Protocol Staking ETP | CH1162108893 | 134.06% | |
| 21Shares Raydium ETP | CH1480821391 | 116.01% | |
| 21Shares Injective Staking ETP | CH1360612134 | 96.57% | |
| 21Shares Uniswap ETP | CH1135202096 | 92.49% | |
| 21shares Hyperliquid Staking ETP | CH1471826029 | 76.60% |
| Name | ISIN | Performance | |
|---|---|---|---|
| 21Shares NEAR Protocol Staking ETP | CH1162108893 | 89.13% | |
| 21shares Hyperliquid Staking ETP | CH1471826029 | 84.32% | |
| 21Shares Raydium ETP | CH1480821391 | 31.15% | |
| 21Shares Uniswap ETP | CH1135202096 | 22.15% | |
| 21Shares Injective Staking ETP | CH1360612134 | 15.74% |
Fundamentaldaten
| Valor | |
| ISIN | XS3303518610 |
| Emittent | H1 Capital |
| Aufgelegt in | Ireland |
| Auflagedatum | 27.02.2026 |
| Kategorie | Anleihen Sonstige |
| Währung | USD |
| Volumen | |
| Depotbank | |
| Geschäftsjahresende | |
| Berichtsstand | 04.11.2026 |
Anlagepolitik
So investiert der H1 Systematic US Allocation (Series 579) Notes due 2046 USD Acc: The investment objective of the strategy is to enhance the risk adjusted performance of U.S. equity exposure over full market cycles by systematically managing drawdowns and volatility during adverse market conditions, while remaining invested during constructive market environments.